Mahamaya Lifesciences Tepid BSE SME Debut
Mahamaya Lifesciences shares made a soft debut on BSE SME, listing at a 2% premium. The stock later surged, hitting the 5% upper circuit. Stay updated on this developing market story.
Category : Search result: Mahamaya Lifesciences
Mahamaya Lifesciences IPO Opens With Nil GMP
Mahamaya Lifesciences IPO subscription begins. The ₹70.44 crore SME issue sees muted interest with a 2% subscription. Check key details, price band, and financials.
Curis Lifesciences IPO: 17x Subscription on Day 1
Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.
Bihar's Political Pioneer: Mahamaya Prasad Sinha's Legacy
Explore the fascinating political legacy of Mahamaya Prasad Sinha, Bihar's first non-Congress CM and mentor to Nitish Kumar, as historical parallels emerge in current political dynamics.
Zydus vs Rubicon: Pharma Stock Analysis
Expert analysis compares Zydus Lifesciences and Rubicon Research in the booming Indian pharmaceutical sector. Discover key financial metrics, growth drivers, and investment outlook for these promising stocks.
Page 1 of 1